Free to Breathe
Free to Breathe is a partnership of lung cancer survivors, advocates, researchers, health-care professionals, and industry leaders united in the belief that every person with lung cancer deserves a cure. Free to Breathe is dedicated to doubling lung cancer survival by 2022. To achieve this transformative vision, Free to Breathe is funding research that has the greatest potential to save lives, increasing the number of lung cancer patients participating in clinical trials, and building and empowering the lung cancer community.